Literature DB >> 22906939

Phage display--a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications.

Justyna Bazan1, Ireneusz Całkosiński, Andrzej Gamian.   

Abstract

One of the most effective molecular diversity techniques is phage display. This technology is based on a direct linkage between phage phenotype and its encapsulated genotype, which leads to presentation of molecule libraries on the phage surface. Phage display is utilized in studying protein-ligand interactions, receptor binding sites and in improving or modifying the affinity of proteins for their binding partners. Generating monoclonal antibodies and improving their affinity, cloning antibodies from unstable hybridoma cells and identifying epitopes, mimotopes and functional or accessible sites from antigens are also important advantages of this technology. Techniques originating from phage display have been applied to transfusion medicine, neurological disorders, mapping vascular addresses and tissue homing of peptides. Phages have been applicable to immunization therapies, which may lead to development of new tools used for treating autoimmune and cancer diseases. This review describes the phage display technology and presents the recent advancements in therapeutic applications of phage display.

Entities:  

Keywords:  antibody libraries; autoimmune diseases; immune-diagnostics; neurological disorders; phage display; transfusion medicine; tumor targeting

Mesh:

Substances:

Year:  2012        PMID: 22906939      PMCID: PMC3656071          DOI: 10.4161/hv.21703

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  163 in total

1.  A system for repertoire cloning and phage display of murine and leporid antibody fragments.

Authors:  Carolin Schüller; Julia C Wiebe; Antje Pegel; Karl Kramer; Arne Skerra; Bertold Hock
Journal:  J AOAC Int       Date:  2010 Jan-Feb       Impact factor: 1.913

2.  Phage display of chelating recombinant antibody libraries.

Authors:  Michael J Wright; Mahendra P Deonarain
Journal:  Mol Immunol       Date:  2007-03-13       Impact factor: 4.407

3.  Regulation of T cell response by blocking the ICOS signal with the B7RP-1-specific small antibody fragment isolated from human antibody phage library.

Authors:  Masatoshi Maeda; Yuji Ito; Takaaki Hatanaka; Shuhei Hashiguchi; Masaharu Torikai; Toshihiro Nakashima; Kazuhisa Sugimura
Journal:  MAbs       Date:  2009-09-26       Impact factor: 5.857

4.  Efficient phage display of intracellularly folded proteins mediated by the TAT pathway.

Authors:  Janina Speck; Katja M Arndt; Kristian M Müller
Journal:  Protein Eng Des Sel       Date:  2011-02-02       Impact factor: 1.650

5.  Competitively selected protein ligands pay their increase in specificity by a decrease in affinity.

Authors:  Silke Hoffmann; Susanne Aileen Funke; Katja Wiesehan; Susanne Moedder; Julian Marius Glück; Sophie Feuerstein; Matthias Gerdts; Jessica Mötter; Dieter Willbold
Journal:  Mol Biosyst       Date:  2009-09-21

6.  A large human domain antibody library combining heavy and light chain CDR3 diversity.

Authors:  Weizao Chen; Zhongyu Zhu; Yang Feng; Dimiter S Dimitrov
Journal:  Mol Immunol       Date:  2009-11-01       Impact factor: 4.407

7.  Rapid isolation of single-chain antibodies by phage display technology directed against one of the most potent marine toxins: Palytoxin.

Authors:  E Garet; A G Cabado; J M Vieites; A González-Fernández
Journal:  Toxicon       Date:  2010-03-16       Impact factor: 3.033

8.  Single-chain Fv antibody fragments retain binding properties of the monoclonal antibody raised against peptide P1 of the human prion protein.

Authors:  Nives Skrlj; Vladka Curin Serbec; Marko Dolinar
Journal:  Appl Biochem Biotechnol       Date:  2009-07-14       Impact factor: 2.926

9.  Active immunization against Alzheimer's beta-amyloid peptide using phage display technology.

Authors:  Beka Solomon
Journal:  Vaccine       Date:  2007-01-22       Impact factor: 3.641

10.  Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy.

Authors:  Yong Hong Chen; Michael Chang; Beverly L Davidson
Journal:  Nat Med       Date:  2009-09-13       Impact factor: 53.440

View more
  46 in total

1.  A peptide mimic blocks the cross-reaction of anti-DNA antibodies with glomerular antigens.

Authors:  Y Xia; E Eryilmaz; E Der; R D Pawar; X Guo; D Cowburn; C Putterman
Journal:  Clin Exp Immunol       Date:  2015-12-08       Impact factor: 4.330

2.  Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.

Authors:  Andreas Lehmann; Josephine H F Wixted; Maxim V Shapovalov; Heinrich Roder; Roland L Dunbrack; Matthew K Robinson
Journal:  MAbs       Date:  2015-09-04       Impact factor: 5.857

3.  Directed evolution and biophysical characterization of a full-length, soluble, human caveolin-1 variant.

Authors:  Joshua N Smith; Joshua M Edgar; J Mark Balk; Mariam Iftikhar; Jessica C Fong; Tivoli J Olsen; Dmitry A Fishman; Sudipta Majumdar; Gregory A Weiss
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2018-05-29       Impact factor: 3.036

Review 4.  High-Throughput Approaches to the Development of Molecular Imaging Agents.

Authors:  Lina Y Hu; Kimberly A Kelly; Julie L Sutcliffe
Journal:  Mol Imaging Biol       Date:  2017-04       Impact factor: 3.488

Review 5.  Design of virus-based nanomaterials for medicine, biotechnology, and energy.

Authors:  Amy M Wen; Nicole F Steinmetz
Journal:  Chem Soc Rev       Date:  2016-07-25       Impact factor: 54.564

6.  Quantitative mapping of protein-peptide affinity landscapes using spectrally encoded beads.

Authors:  Jagoree Roy; Björn Harink; Nikhil P Damle; Huy Quoc Nguyen; Naomi R Latorraca; Brian C Baxter; Kara Brower; Scott A Longwell; Tanja Kortemme; Kurt S Thorn; Martha S Cyert; Polly Morrell Fordyce
Journal:  Elife       Date:  2019-07-08       Impact factor: 8.140

7.  Human erythrocyte band 3 is a host receptor for Plasmodium falciparum glutamic acid-rich protein.

Authors:  Haifa Almukadi; Christopher Schwake; Maima M Kaiser; D C Ghislaine Mayer; James Schiemer; Michael R Baldwin; Shreeya Hegde; Yunzhe Lu; Toshihiko Hanada; Athar H Chishti
Journal:  Blood       Date:  2018-12-13       Impact factor: 22.113

Review 8.  Bacteriophage Capsid Modification by Genetic and Chemical Methods.

Authors:  Caitlin M Carmody; Julie M Goddard; Sam R Nugen
Journal:  Bioconjug Chem       Date:  2021-03-04       Impact factor: 4.774

Review 9.  Phage engineering and the evolutionary arms race.

Authors:  Huan Peng; Irene A Chen
Journal:  Curr Opin Biotechnol       Date:  2020-10-23       Impact factor: 9.740

10.  Simultaneous Inhibition of Three Major Cytokines and Its Therapeutic Effects: A Peptide-Based Novel Therapy against Endotoxemia in Mice.

Authors:  Hung-Jen Shih; Chao-Yuan Chang; Milton Chiang; Van Long Le; Hao-Jen Hsu; Chun-Jen Huang
Journal:  J Pers Med       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.